Comments on the MRC/BHF Heart Protection Study
- PMID: 12957102
- DOI: 10.1016/S0140-6736(03)14213-4
Comments on the MRC/BHF Heart Protection Study
Comment on
-
Major benefits from cholesterol-lowering in patients with diabetes.Lancet. 2003 Jun 14;361(9374):2000-1. doi: 10.1016/S0140-6736(03)13672-0. Lancet. 2003. PMID: 12814705 No abstract available.
-
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.Lancet. 2003 Jun 14;361(9374):2005-16. doi: 10.1016/s0140-6736(03)13636-7. Lancet. 2003. PMID: 12814710 Clinical Trial.
Similar articles
-
Comments on the MRC/BHF Heart Protection Study.Lancet. 2003 Aug 30;362(9385):744; author reply 744-5. doi: 10.1016/S0140-6736(03)14212-2. Lancet. 2003. PMID: 12957101 No abstract available.
-
Comments on the MRC/BHF Heart Protection Study.Lancet. 2003 Aug 30;362(9385):745-6. doi: 10.1016/S0140-6736(03)14215-8. Lancet. 2003. PMID: 12957104 No abstract available.
-
Comments on the MRC/BHF Heart Protection Study.Lancet. 2003 Aug 30;362(9385):744; author reply 744-5. doi: 10.1016/S0140-6736(03)14211-0. Lancet. 2003. PMID: 12957100 No abstract available.
-
[CARE[ Cholesterol and Recurrent Events Trial]].Nihon Rinsho. 2001 Mar;59 Suppl 3:427-32. Nihon Rinsho. 2001. PMID: 11347108 Review. Japanese. No abstract available.
-
Statin therapy for prevention of coronary artery disease with average cholesterol levels.Indian Heart J. 1999 Jan-Feb;51(1):19-20, 105. Indian Heart J. 1999. PMID: 10327772 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources